Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,190 | 31,269 | 41,625 | 31,062 | 51,536 |
| Marketable Securities | 364,506 | 244,693 | 165,135 | 57,682 | N/A |
| Receivables | 26,198 | 19,928 | 17,588 | 28,196 | 9,860 |
| Inventories | 4,910 | 5,424 | 4,732 | 4,576 | 2,329 |
| TOTAL | $478,501 | $307,358 | $236,820 | $124,185 | $65,689 |
| Non-Current Assets | |||||
| PPE Net | 1,675 | 1,050 | 655 | 518 | 205 |
| Investments And Advances | 36,196 | 39,352 | 0 | 15,281 | 0 |
| Other Non-Current Assets | 55,359 | 64,552 | 74,219 | 80,553 | 2,859 |
| TOTAL | $93,230 | $104,954 | $74,874 | $96,352 | $3,064 |
| Total Assets | $571,731 | $412,312 | $311,694 | $220,537 | $68,753 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 14,664 |
| Accounts payable and accrued liabilities | 10,554 | 7,537 | 8,266 | 8,579 | 2,290 |
| Accrued Expenses | 13,704 | 6,477 | 3,521 | 2,247 | 1,467 |
| TOTAL | $47,494 | $38,841 | $35,573 | $29,569 | $27,374 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 501 | 1,903 | 0 | 0 | 0 |
| TOTAL | $899 | $2,289 | $239 | $N/A | $N/A |
| Total Liabilities | $48,393 | $41,130 | $35,812 | $29,569 | $27,374 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,312 | 114,595 | 114,723 | 114,830 | 112,942 |
| Common Shares | 122 | 120 | 117 | 115 | 113 |
| Retained earnings | 82,456 | -23,555 | -117,736 | -193,146 | -322,268 |
| Other shareholders' equity | 620 | 557 | 273 | -75 | 0 |
| TOTAL | $523,338 | $371,182 | $275,882 | $190,968 | $41,379 |
| Total Liabilities And Equity | $571,731 | $412,312 | $311,694 | $220,537 | $68,753 |